What it’s for
- Selected cardiovascular prevention
A medicine with pain-relieving and antiplatelet effects, depending on dose.
Purpose, evidence and practical considerations.
For prevention of a first cardiovascular event, potential benefit is small and must be weighed against bleeding. This is different from treatment after established cardiovascular disease.
Confidence: strong
Gastrointestinal and intracranial bleeding are important risks. Anticoagulants, other antiplatelet drugs, ulcers and some pain medicines increase risk. Do not start or stop prescribed aspirin based on a copied protocol.
Aspirin inhibits cyclooxygenase and reduces platelet aggregation at low doses. Prevention benefit depends on cardiovascular and bleeding risk.
Regulatory status: Available without prescription in many settings; preventive use needs clinical assessment.
How people use it, with their schedules, context and original sources.
a baby aspirin · Daily
a "soft call" for cardio-protection; he called the evidence "pretty weak" but judged his bleeding risk low at his age
Dose and schedule patterns reported in public protocols; these are observations, not prescribing advice. Private and hidden usage is excluded.
daily
These share a protocol with this intervention. This does not establish that they work together or are suitable alternatives.